XOMA Corporation (XOMA)
NASDAQ: XOMA · IEX Real-Time Price · USD
25.44
-0.38 (-1.47%)
May 2, 2024, 4:00 PM EDT - Market closed
XOMA Corporation Revenue
In the year 2023, XOMA Corporation had annual revenue of $4.76M, a decrease of -21.06%. Revenue in the quarter ending December 31, 2023 was $1.83M with 23.35% year-over-year growth.
Revenue (ttm)
$4.76M
Revenue Growth
-21.06%
P/S Ratio
62.16
Revenue / Employee
$366,000
Employees
13
Market Cap
295.76M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 4.76M | -1.27M | -21.06% |
Dec 31, 2022 | 6.03M | -32.13M | -84.21% |
Dec 31, 2021 | 38.16M | 8.78M | 29.86% |
Dec 31, 2020 | 29.39M | 11.02M | 59.96% |
Dec 31, 2019 | 18.37M | 13.07M | 246.67% |
Dec 31, 2018 | 5.30M | -47.39M | -89.94% |
Dec 31, 2017 | 52.69M | 47.13M | 846.98% |
Dec 31, 2016 | 5.56M | -49.88M | -89.97% |
Dec 31, 2015 | 55.45M | 36.58M | 193.90% |
Dec 31, 2014 | 18.87M | -16.59M | -46.78% |
Dec 31, 2013 | 35.45M | 1.67M | 4.94% |
Dec 31, 2012 | 33.78M | -24.41M | -41.95% |
Dec 31, 2011 | 58.20M | 24.56M | 72.99% |
Dec 31, 2010 | 33.64M | -64.79M | -65.82% |
Dec 31, 2009 | 98.43M | 30.44M | 44.78% |
Dec 31, 2008 | 67.99M | -16.27M | -19.31% |
Dec 31, 2007 | 84.25M | 54.75M | 185.62% |
Dec 31, 2006 | 29.50M | 10.83M | 58.01% |
Dec 31, 2005 | 18.67M | 15.00M | 409.39% |
Dec 31, 2004 | 3.67M | -20.75M | -84.99% |
Dec 31, 2003 | 24.41M | -5.54M | -18.49% |
Dec 31, 2002 | 29.95M | 12.67M | 73.33% |
Dec 31, 2001 | 17.28M | 10.62M | 159.48% |
Dec 31, 2000 | 6.66M | 4.30M | 182.04% |
Dec 31, 1999 | 2.36M | -3.98M | -62.79% |
Dec 31, 1998 | 6.35M | -12.04M | -65.48% |
Dec 31, 1997 | 18.38M | 14.78M | 410.07% |
Dec 31, 1996 | 3.60M | 2.44M | 209.36% |
Dec 31, 1995 | 1.17M | -564.00K | -32.62% |
Dec 31, 1994 | 1.73M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Kamada | 142.52M |
Nektar Therapeutics | 90.12M |
Pulmonx | 68.68M |
Aquestive Therapeutics | 50.58M |
Verrica Pharmaceuticals | 5.12M |
Inovio Pharmaceuticals | 832.01K |
XOMA News
- 7 days ago - XOMA Earns $9 Million Milestone as FDA Grants Accelerated Approval to Day One's OJEMDATM (tovorafenib) for Relapsed or Refractory BRAF-altered Pediatric Low-Grade Glioma (pLGG) - GlobeNewsWire
- 8 days ago - Actym Therapeutics Appoints Thomas Smart as CEO - PRNewsWire
- 4 weeks ago - XOMA Corporation Announces Closing of Tender Offer - GlobeNewsWire
- 6 weeks ago - XOMA Declares Quarterly Preferred Stock Dividends - GlobeNewsWire
- 6 weeks ago - XOMA Announces Calculation of Additional Price Per Share and Extension of Expiration Date for Tender Offer for Kinnate Biopharma Inc. - GlobeNewsWire
- 7 weeks ago - KINNATE BIOPHARMA INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Kinnate Biopharma Inc. - KNTE - Business Wire
- 7 weeks ago - XOMA Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent and Upcoming Events Expected to Drive Shareholder Value - GlobeNewsWire
- 2 months ago - XOMA to Present at Upcoming Investor Conferences in March - GlobeNewsWire